Bone Metastases in Neuroendocrine Neoplasms: From Pathogenesis to Clinical Management
Thanks to the improvement of therapeutic options, which results in longer survival, and of imaging techniques, particularly after the introduction of positron emission tomography (PET) with gallium peptides, the diagnosis of bone metastases (BMs) in NENs is increasing.
You can read more here: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770134/
#NeuroendocrineCancer #NETCancer #NeuroendocrineCancerUK #BoneMetastases #NeuroendocrineNeoplasms
